Topic Archives: psoriasis

Comments

  • The "Forces Abroad that won’t want to see broad adoption of devices that give patients an instant answer to that worry...

  • $KALTF > Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps Websit...

  • $KDMN $Question to all Hi all. EDIT: The formatting of this comment is refusing to settle correctly. I am not a fa...

  • $DERM LONG Dermira (DERM 26.53) target lowered to $39 from $43 at Mizuho. Firm notes update their model post-3Q:17, ...

  • AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment Today 8:12 AM ET (MarketWatch) Sh...

  • #vanillin Thanks for this Frank. Who da thunk skin rubbing with artificial vanilla, real vanilla won’t do, would red...

  • Oh, believe me, we don't differ. If the call were mine, I would never chase psoriasis as an indication. My impetus in th...

  • Very interesting insight, Doc. Much appreciated. I do have one point where we differ and thought I’d voice my thoughts...

  • $AUPH Doc, I was wondering about psoriasis as well. I know the company they combined with named Isotechnica went all t...

  • Agree with above. I wanted to add that in his presentation, Glickman noted it is entirely possible that Aurinia could be...

  • $IPIX np. Dr KSS, do you think their Prurisol still has a chance? I've a sister with Psoriasis.......

  • Joe: As I recall, from last time I looked in on $CTIX, they are still trialing brilacidin for oral mucositis in oncology...

  • $AUPH long Some historical DD. Looking at clinical trials.gov, before 2012, there were trials evaluating voclosporin,...

  • Yes, we've discussed Galectin at length in the past. Early on I gave them the intellectual benefit of doubt and did vast...

  • I was interested on Dr. KSS or others thoughts on GALT , Galectin Therapeutics , it pipe line is targeting galectin usin...

  • Re: $AUPH jumboh, I'll refer you to two comments made by Dr. KSS in this post; hopefully he can elaborate more abo...

  • $SNGX: I want to cover this rare diseases company, Solginex which is currently trading in the vicinity of 52-week lows w...

  • I would challenge the assertion that Humira is the top selling drug world wide. REMICADE was the first patentable monoc...

  • Here is Dr KSS comments on psoriasis, etc.... Author: Dr. KSS MD PhD Comment: Hi: the first thing I'd suggest i...

  • wmrw, shall continue looking for you.... re: psoriasis #NASH... remember several #ZKSS posts on the subject over the y...

  • Hi, This paper, published in 2015, was the first major publication linking psoriasis with non-alcoholic fatty liver. Cou...

  • wmrw, type in 'psoriasis' in the little box labeled Comment Search just below and right of where you type in a post and...

  • Hi Jack, I have been searching for about an hour and I can't find the Dr. KSS post you are referring to here about Psor...

  • Dr. Kiss, I read with great interest the post about the link between psoriasis and NAFLD. Of late, I've been gaining...

  • #Psoriasis May Be Associated with #LiverDisease, Research Shows. #Hepatology http://ow.ly/cJ5q3089iDs $GNFT #NASH https...

  • $DERM np; Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to...

  • $OWCP np - Copied from: There is a new comment on: What's the pre-election "Secret '$50 Marijuana Stock Blueprint'" Pit...

  • OWCP -- OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One W...

  • $PHMD Investor Information: Corporate Profile PhotoMedex is a global skin health company providing integrated diseas...

  • $ctix - I have a bit of CTIX - comparing with cempra seems like a real bargain about 1/3 the mkt cap and has Brilacidin ...

  • $CTIX update We would like to inform shareholders that clinicaltrials.gov has updated its website to include our Phase 2...

  • $CTIX Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis ht...

  • Question of the Week: Aurinia $AUPH is developing voclosporin, a calcineurin inhibitor, for lupus nephritis. Which on...

  • As a person with psoriasis, a virtually incurable condition, there is one thing I have come to understand: What is good...

  • $GNFT : and here is the press release in English: http://www.genfit.com/wp-content/uploads/2016/09/160923_PR_GENFIT-RORg...

  • $CTIX conferences Sept 9 and 19th Cellceutix Corporation to Present at Upcoming Conferences BEVERLY, MA--(Marketwire...

  • Hi Dan: The Fibroscan method is a non-invasive method of assessing fibrosis, but has its limitations. In the case of the...

  • $CTIX: Cellceutix to Initiate Phase 2b Trial of Prurisol for Chronic Plaque Psoriasis - Yahoo Finance via Helen https://...

  • Thanks Anshuman. Ah, the corporate kabuki....the glissando of insincerity.....the half-executed pirouettes: they extend ...

  • $CTIX Doc thought you'll find this useful from the latest press release. I think CTIX has a good drug on hand with Pu...

  • This event does, to a significant degree, rekindle my interest in $CTIX. They seem to be making no excuses here, and tho...

  • Re: $CTIX Cellceutix phase2 trial of prurisol for mild to moderate psoriasis meets primary endpoint http://cellceuti...

  • $CCXI Reading thru the full data set its obvious; CCX168 is a stellar drug. I beats standard of care on every measure...

  • $CCXI Chemocentryx are on a manic roll! Now they take on psoriasis. --- "ChemoCentryx Announces Data Presentation o...

  • $CTIX is indulging in funny compounds. Prurisol actually abacavir that approved for HIV/AIDS. https://en.wikipedia.org...

  • $CTIX Cellceutix Concludes Last Patient Visit in Phase 2 FDA Trial of Oral Dosed Prurisol in Patients With Mild-to-Mode...

  • $ABBV Again from ETF Channel, AbbVie is a research-based biopharmaceutical company that develops and markets therapies ...

  • XNPT- XenoPort, Inc. (NASDAQ: XNPT) shares rose 8.32 percent to $7.29 in pre-market trading after the company reported p...

  • I couldn't figure out why Robert Frost was buying so much OPK. I can't get excited about an anti emetic drug. He has bou...

  • Re: Prednisone side effects. I had a coworker for many years, started as a bright young lad, on the tall side, slender,...

  • I might be wrong here, but I think I can shed a little light on why Doc's thinking has changed. First, he said that he's...

  • Thanks for the time and thanks to the gang that were there, though cut off from their comments by Erhlich. Regarding Pru...

  • CTIX- Cellceutix Provides Insights to its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Can...

  • CTIX- BEVERLY, MA--(Marketwired - August 6, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage...

  • $CTIX......Prurisol trial commences......Dr. Alexander resigns due to health concerns Cellceutix Commenc...

  • $ RCPT: Kenny G you may just get your wish: A Counter Offer For Receptos Inc From Another Bidder Is Possible: Wed...

  • It’s a Novartis world – everybody else just lives in it Source EP Vantage Company Novartis, Actavis, AstraZeneca...

  • Very Interesting. Thanks for That. Having read this article in its entirety I have the following comments: May also h...

  • CTIX- News this a.m. - BEVERLY, MA--(Marketwired - June 08, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company")...

  • Thanks for sharing. I have psoriasis and this is good to know. I always suspected there were dietary causes (at least in...

  • Psoriasis- Who is NOT chasing this disease? http://www.researchandmarkets.com/research/6v7xbn/psoriasis Best2ALL!-Ben...

  • My late father-in law had Psoriasis, the symptom of which was loss of skin from his head, arms and upper body. The condi...

  • People interested in a variety of treatments for Psoriasis can learn about a promising new drug under clinical study rig...

  • I have both psoriasis and psoriatic arthritis, a bad case of it.. It just happened to me at about 33 years old, I am 42...

  • I had psoriasis from age 7 and intermittently until ~8 years ago. I am 62 years old, 6'2" and 175#, active male. 8 yea...

  • Is Merck out in front in psoriasis race? http://www.nature.com/nature/journal/v521/n7551/full/nature14175.html#affil-...

  • 478.Prothena $PRTA At least six companies are targeting Parkinson's, most preclinical. Two, Amicus ($FOLD - pre-clini...

  • $ PRTA $ DYAX $ ESPR Before you said WHOA !, I checked DYAX and the number three holding at XBI, PROTHENA PRTA. ...

  • Jeff---I am pretty ambivalent. This is a bizarre small molecule that nonspecifically affects a number of inflammatory me...

  • Doc, no need for a full analysis, but do you have any thoughts on the likelihood of positive results fror Can-Fite's Pha...

  • $CANF Can-Fite BioPharma Ltd.'s CEO Pnina Fishman Interviewed by The Life Sciences Report 9:00a ET March 5, 2015 (Ma...

  • CNDO-its plans to use gut parasites to treat psoriasis and autism are not grounded in reality DBMD – the shortcut to t...

  • Vascular Biologics $VBLT cratering 46 percent in pre-market. Its "lecinoxoids" for UC and psoriasis, which reek of BS, p...

  • Re the Dungeon spreadsheet: In my finite way of infinite thinking, there should have been levels of incarceration. ...

  • I'm totally lost. We need to straighten out this thread somehow. I'll post here since I don't know where else to do it....

  • AUPH -- From Scottrade: - "Aurinia Pharmaceuticals Inc., formerly Isotechnika Pharma Inc., is an international biopharm...

  • Virtual presence @ SFO Biotech of Cellceutix presentation Cellceutix Invites All to Attend Company’s Live Webca...

  • Few positive data points for NVS in the recent past Novartis' Cosentyx Approved in Japan for Psoriatic Arthritis yester...

  • Few positive data points for NVS in the recent past Novartis' Cosentyx Approved in Japan for Psoriatic Arthritis yester...

  • Yes Michael Yee of RBC talking with Melissa Lee. We discussed this somewhere here recently. It all depends on what one "...

  • CNDO-Another one to feed our dragons Hi Pockets ha- From TLOGlolytes post 157- To Ben/sogiam: I think you were asking o...

  • To Ben/sogiam: I think you were asking on another thread about Coronado Biosciences $CNDO. This company has a strongly p...

  • Last night we were discussing a new fumaric acid product, similar in some ways to Tecfidera, that might be used against ...

  • Thanks Doc; I probably wasn't clear. They are in Phase 2 for psoriasis using XP23829; not clear who the competition is....

  • Yes...it;s likely to work for MS, but may face patent issues in addition to the fact that, hey, what will it face for co...

  • I haven't seen this one mentioned but it looks potentially interesting. Xenoport ($XENO) actually had positive net inc...

  • Thanks Ben...well this is very good news indeed. Glad you found it. This is an oral agent where, based on mechanism of a...

  • CTIX-Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin 7:40a ET December 10, 2014 (Mark...

  • I think people need to realize that if Prurisol works, given the mechanism, that it will totally topple a dozen psoriasi...

  • Glenn: Can Fite is worth a look. I suspect its CF101 will succeed in psoriasis phase 3, though to really get a feel f...

  • One I find interesting and has a lot of catalysts coming up especially their CF-102 drug for psoriasis and rheumatoid ar...

  • Doc Kss, do you think Can-fite drug for Psoriasis CF101 has a good shot to get past phase 3? I like CTIX Prurisol if the...

  • From the headlines, I thought the stock was Antares Pharma (ATRS), but then as I read the clues, figured it it wasn't. ...

  • Thanks Patrick. I presume this is to provide funding for brilacidin phase 3 skin infections and for Prurisol phase 2 pso...

  • Recent IPO Dermira ($DERM) is getting lots of analyst attention today. This is a company that has made a deal with UCB (...

  • Actually, I did mention off-label use, in the section about biosimilars perhaps being better than the original. And, y...

  • Please note that psoriasis causes psoriatic arthritis, and not RA....

  • Sharon: I think you make a fine point, which is that physicians treating lipids in people with other conditions, such as...

  • $CELG's apremilast has some promise for it, though that promise is totally dwarfed by CTIX's Prurisol. That a PDE inhibi...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info